Eurocine Vaccines AB (8X4) Stock Overview

Eurocine Vaccines AB (publ) engages in the development of vaccines in Sweden. The company is developing Herpes Simplex Virus type 2 and Chlamydia vaccines. Eurocine Vaccines AB (publ) was incorporated in 1999 and is based in Solna, Sweden.

8X4 Stock Information

Symbol

8X4

Address

Nanna Svartz vag 4Solna, 171 65Sweden

Founded

Trading hours

Website

https://www.eurocine-vaccines.com

Country

🇸🇪 Sweden

Phone Number

46 7 06 34 01 71

Eurocine Vaccines AB (8X4) Price Chart

Eurocine Vaccines AB Overview: Key Details and Summary

Stock data	2023	Change
Price	$0.0015560742469712125	N/A
Market Cap	$129.27K	N/A
Shares Outstanding	83.07M	68.24%
Employees	3.00	N/A
Shareholder Equity	3.21M	-79.39%

Valuation	2023	Change
P/E Ratio	-0.01	N/A
P/B Ratio	0.04	N/A

Growth	2023	Change
Return on Equity	-0.5600	N/A

Earnings	2023	Change
Revenue	$0	N/A
Earnings	-$1.80M	N/A
EPS	-0.2333	N/A
Earnings Yield	-149.90	N/A

Financial Strength	2023	Change
Total Assets	$546.02K	N/A
Cash on Hand	$102.17K	N/A
Debt to Equity	0.0721	256.95%
Current Ratio	$2.36	-59.69%